Atsuo Maruta

High Complete Remission Rate and Promising Outcome by Combination of Imatinib and Chemotherapy for Newly Diagnosed <i>BCR</i>-<i>ABL</i>–Positive Acute Lymphoblastic Leukemia: A Phase II Study by the Japan Adult Leukemia Study Group

Masamitsu Yanada, Jin Takeuchi, Isamu Sugiura et al. · Journal of Clinical Oncology · 2005 · 454 citations · Full text

Medicine, Hematology, Oncology +15

Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/ myelodysplastic syndrome and de novo acute myeloid leukemia.

Tomoki Naoe, Kunihiko Takeyama, Toshiya Yokozawa et al. · PubMed · 2000 · 190 citations

Medicine, Genetics, Molecular Genetics +15

The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation

Kazuteru Ohashi, Juichi Tanabe, Reiko Watanabe et al. · American Journal of Hematology · 2000 · 151 citations

Medicine, Pharmacotherapy, Surgery +12

Clinical Significance of Inhibitors in Acquired von Willebrand Syndrome

Hiroshi Mohri, Shigeki Motomura, Heiwa Kanamori et al. · Blood · 1998 · 130 citations · Full text

Medicine, Pharmacotherapy, Clinical Pharmacology +11

Prospective monitoring of <i>BCR‐ABL1</i> transcript levels in patients with Philadelphia chromosome‐positive acute lymphoblastic leukaemia undergoing imatinib‐combined chemotherapy

Masamitsu Yanada, Isamu Sugiura, Jin Takeuchi et al. · British Journal of Haematology · 2008 · 101 citations · Full text

Medicine, Hematology, Oncology +17